-
Je něco špatně v tomto záznamu ?
Insulin-like growth factor axis in pregnancy and gestational diabetes mellitus
K. Anderlová, A. Cinkajzlová, P. Šimják, J. Kloučková, H. Kratochvílová, Z. Lacinová, P. Kaválková, H. Krejčí, M. Mráz, A. Pařízek, M. Haluzík, M. Kršek
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
Grantová podpora
NV15-27630A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- biologické markery krev MeSH
- časové faktory MeSH
- dospělí MeSH
- gestační diabetes diagnóza genetika krev MeSH
- gestační stáří MeSH
- krevní glukóza metabolismus MeSH
- lidé MeSH
- nitrobřišní tuk metabolismus MeSH
- podkožní tuk metabolismus MeSH
- poporodní období krev MeSH
- proteiny vázající insulinu podobné růstové faktory genetika krev MeSH
- receptory somatomedinů genetika krev MeSH
- regulace genové exprese MeSH
- somatomediny genetika metabolismus MeSH
- studie případů a kontrol MeSH
- těhotenství MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
The insulin-like growth factor (IGF) is involved in the regulation of growth and metabolism. The aim of this study was to determine selected parameters of IGF system at systemic and local levels [subcutaneous (SAT) and visceral adipose tissue (VAT)] to assess its possible role in gestational diabetes mellitus (GDM). 37 pregnant women (21 with GDM and 16 without GDM) and 15 age-matched non-pregnant females were included in the study. Blood samples were taken in 28-32 and 36-38 weeks of gestation and 6-12 months after delivery. SAT and VAT samples were obtained during delivery or surgery. Compared with non-pregnant women, serum IGF-1 and IGFBP-3 were increased in both groups of pregnant women. IGF-2 was elevated only in GDM women from 36 weeks of gestation culminating 6 months after delivery (p=0.003). Serum IGFBP-3 was increased and IGFBP-4 decreased in GDM women vs. pregnant women without GDM during the whole study (IGFBP-3: p?0.001 for GDM vs. non-GDM; IGFBP-4: p=0.004 for GDM vs. non-GDM). Pregnant women with GDM had decreased mRNA expression of IGF-1, IGF-1R and IGF-2R and IGFBP-4 in VAT and IGF-1R in SAT compared to pregnant women without GDM. Changes in local activity of IGF are associated with the development of GDM.
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20005493
- 003
- CZ-PrNML
- 005
- 20201018163114.0
- 007
- ta
- 008
- 200511s2019 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.934093 $2 doi
- 035 __
- $a (PubMed)31424259
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Anderlová, Kateřina $7 xx0070229 $u Gynaecology and Obstetrics Department, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Third Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 245 10
- $a Insulin-like growth factor axis in pregnancy and gestational diabetes mellitus / $c K. Anderlová, A. Cinkajzlová, P. Šimják, J. Kloučková, H. Kratochvílová, Z. Lacinová, P. Kaválková, H. Krejčí, M. Mráz, A. Pařízek, M. Haluzík, M. Kršek
- 504 __
- $a Literatura
- 520 3_
- $a The insulin-like growth factor (IGF) is involved in the regulation of growth and metabolism. The aim of this study was to determine selected parameters of IGF system at systemic and local levels [subcutaneous (SAT) and visceral adipose tissue (VAT)] to assess its possible role in gestational diabetes mellitus (GDM). 37 pregnant women (21 with GDM and 16 without GDM) and 15 age-matched non-pregnant females were included in the study. Blood samples were taken in 28-32 and 36-38 weeks of gestation and 6-12 months after delivery. SAT and VAT samples were obtained during delivery or surgery. Compared with non-pregnant women, serum IGF-1 and IGFBP-3 were increased in both groups of pregnant women. IGF-2 was elevated only in GDM women from 36 weeks of gestation culminating 6 months after delivery (p=0.003). Serum IGFBP-3 was increased and IGFBP-4 decreased in GDM women vs. pregnant women without GDM during the whole study (IGFBP-3: p?0.001 for GDM vs. non-GDM; IGFBP-4: p=0.004 for GDM vs. non-GDM). Pregnant women with GDM had decreased mRNA expression of IGF-1, IGF-1R and IGF-2R and IGFBP-4 in VAT and IGF-1R in SAT compared to pregnant women without GDM. Changes in local activity of IGF are associated with the development of GDM.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a krevní glukóza $x metabolismus $7 D001786
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a gestační diabetes $x diagnóza $x genetika $x krev $7 D016640
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a regulace genové exprese $7 D005786
- 650 _2
- $a gestační stáří $7 D005865
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a proteiny vázající insulinu podobné růstové faktory $x genetika $x krev $7 D018969
- 650 _2
- $a nitrobřišní tuk $x metabolismus $7 D050152
- 650 _2
- $a poporodní období $x krev $7 D049590
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a receptory somatomedinů $x genetika $x krev $7 D017451
- 650 _2
- $a somatomediny $x genetika $x metabolismus $7 D013002
- 650 _2
- $a podkožní tuk $x metabolismus $7 D050151
- 650 _2
- $a časové faktory $7 D013997
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Cinkajzlová, Anna $7 xx0228108 $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Šimják, Patrik $7 xx0221733 $u Gynaecology and Obstetrics Department, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Kloučková, Jana $7 xx0232313 $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Kratochvílová, Helena, $d 1992- $7 xx0228161 $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Lacinová, Zdeňka $7 xx0062138 $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Third Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Kaválková, Petra $7 xx0094376 $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Krejčí, Hana, $d 1974- $7 xx0036968 $u Gynaecology and Obstetrics Department, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic;
- 700 1_
- $a Mráz, Miloš $7 xx0119173 $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Department of Diabetes, Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Pařízek, Antonín, $d 1959- $7 mzk2005294935 $u Gynaecology and Obstetrics Department, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Haluzík, Martin, $d 1970- $7 xx0000707 $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Department of Diabetes, Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Department of Obesitology, Institute of Endocrinology, Prague, Czech Republic, 7Second Department of Internal Medicine, Third Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic
- 700 1_
- $a Kršek, Michal, $d 1964- $7 xx0046428 $u Third Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Second Department of Internal Medicine, Third Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 68, č. 5 (2019), s. 807-816
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31424259 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20201018163114 $b ABA008
- 999 __
- $a ok $b bmc $g 1528594 $s 1095548
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 68 $c 5 $d 807-816 $e 20190819 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- GRA __
- $a NV15-27630A $p MZ0
- LZP __
- $b NLK118 $a Pubmed-20200511